
GC31906
NE 52-QQ57
Also known as 2-[4-[(2-ethyl-5,7-dimethylpyrazolo[1,5-a]pyrimidin-3-yl)methyl]phenyl]-5-piperidin-4-yl-1,3,4-oxadiazole
NE 52-QQ57 is a selective, and orally available GPR4 antagonist with an IC50 of 70 nM
ChemicalCAS1401728-56-0MW416.52FormulaC24H28N6O
- CAS number
- 1401728-56-0
- Molecular weight
- 416.52
- Formula
- C24H28N6O
- Solubility
- DMSO : 25 mg/mL (60·02 mM)
- InChIKey
- HXPQWNPLNIEJOW-UHFFFAOYSA-N
- Catalogue number
- GC31906
- Brand
- GLPBIO
Computed properties PubChem CID 68379135 · XLogP 3.5 · TPSA 81.1 Ų · H-bond donors 1
- XLogP
- 3.5
- TPSA
- 81.1 Ų
- H-bond donors
- 1
- H-bond acceptors
- 6
- Rotatable bonds
- 5
- Heavy atoms
- 31
SMILES CCC1=NN2C(=CC(=NC2=C1CC3=CC=C(C=C3)C4=NN=C(O4)C5CCNCC5)C)C
Computed descriptors from PubChem (CID 68379135), public domain. Identity cross-checked against the supplier's molecular formula and weight — verify before use.
Ordering in Israel
- Lead time
- Ships from the manufacturer to your lab in 8–14 business days; customs and cold chain handled by LABO Scientific.
- Pricing
- Quoted in ILS, excl. VAT. Add the item to your quote and we confirm the final price, usually the same business day.
- Documents
- Lot certificate of analysis and manufacturer SDS are emailed with your order confirmation.
- Who we serve
- Universities, hospitals and biotech companies across Israel. Research use only — not for diagnostic or therapeutic use.
- Questions
- WhatsApp · +972-55-990-7576 · orders@labo.co.il